Transforming growth factor-β increases interleukin-6 transcripts in osteoblasts

Bone

Volumn 26, Issue 3, 2000, Pages 249-253

  Franchimont, N ^a,c   Rydziel, S ^a   Canalis, E ^a,b  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c CHU SART TILMAN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; BONE REMODELING; CELL CULTURE; DOSE TIME EFFECT RELATION; FETUS; IN VITRO STUDY; NONHUMAN; NORTHERN BLOTTING; OSTEOBLAST; OSTEOLYSIS; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; DNA PRIMERS; INTERLEUKIN-6; OSTEOBLASTS; RATS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033976120     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00275-6     Document Type: Article

References (34)

1. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. Preparation and analysis of RNA. In: Ausubel, F. M., Kingston, R. E., Seidman, J. G., Brent, R., Moore, D. D., and Smith, J. A., Eds. Current Protocols in Molecular Biology. New York: Wiley; 1995; 4.10.5-4.10.9.
2. Canalis, E. Regulation of bone remodeling. In: Favus, M. J., Eds. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 3rd ed. Philadelphia: Lippincott-Raven; 1996; 29-34.
3. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanayte-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
4. Dieudonne S.C., Foo P., van Zoelen E.J., Burger E.H. Inhibiting and stimulating effects of TGF-beta 1 on osteoclastic bone resorption in fetal mouse bone organ cultures. J Bone Miner Res. 6:1991;479-487.
5. Eickelberg O., Pansky A., Mussman R., Bihl M., Tamm M., Hildebrand P., Perruchoud A.P., Roth M. Transforming growth factor-β1 induces interleukin-6 expression via activating protein-1 consisting of Jun D homodimers in primary lung fibroblasts. J Biol Chem. 274:1999;12933-12938.
6. Feinberg A.P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 137:1984;266-267.
7. Feyen J.H., Elford P., Di Padova F.E., Trechsel U. Interleukin-6 is produced by bone and modulated by parathyroid hormone. J Bone Miner Res. 4:1989;633-638.
8. Franchimont N., Vrindts Y., Gaspar S., Lopez M., Gathy R., DeGroote D., Reginster J.Y., Franchimont P. Parathyroid hormone (1-34) and 1,25(OH)2 vitamin D3 inhibits leukemia inhibitory factor (LIF) production by osteoblasts in vitro. Christiansen C., Riis B. Proceedings 1993 Fourth International Symposium on Osteoporosis and Consensus Development Conference . 1993;249-250 Handelstrykkeriet Aalborg ApS, Aalborg, Denmark.
9. Franchimont N., Canalis E. Platelet-derived growth factor stimulates the synthesis of interleukin-6 in cells of the osteoblast lineage. Endocrinology. 136:1995;5469-5475.
10. Franchimont N., Rydziel S., Canalis E. Interleukin-6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells. J Clin Invest. 100:1997;1797-1803.
11. Franchimont N., Rydziel S., Delany A.M., Canalis E. Interleukin-6 and its soluble receptor cause a marked induction of collagenase 3 expression in rat osteoblast cultures. J Biol Chem. 272:1997;12144-12150.
12. Franchimont N., Durant D., Canalis E. Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures. Endocrinology. 138:1997;3380-3386.
13. Franchimont N., Gangji V., Durant D., Canalis E. Interleukin-6 with its soluble receptor enhances the expression of insulin-like growth factor-I in osteoblasts. Endocrinology. 138:1997;5248-5255.
14. Franchimont N., Durant D., Rydziel S., Canalis E. Platelet-derived growth factor induces interleukin-6 transcription in osteoblasts through the activator protein-1 complex and activating transcription factor-2. J Biol Chem. 274:1999;6783-6789.
15. Girasole G., Pedrazzon M., Giuliani N., Passeri G., Passeri M.J. Increased serum soluble interleukin-6 receptor levels are induced by ovariectomy, prevented by estrogen replacement and reversed by alendronate administration. J Bone Miner Res. 10:(Suppl.):1995;S160.
16. Greenberg M.E., Ziff E.B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature. 311:1984;433-438.
17. Hattersley G., Chambers T.J. Effects of transforming growth factor beta 1 on the regulation of osteoclastic development and function. J Bone Miner Res. 6:1991;165-172.
18. Helle M., Brakenhoff J.P.J., DeGroot E.R., Aarden L.A. Interleukin-6 is involved in interleukin-1-induced activities. Eur J Immunol. 18:1988;957-959.
19. Horowitz M., Phillips J., Centrella M. TGF-β regulates interleukin-6 secretion by osteoblasts. Cohn D.V., Gennari C., Tashjian A.H. Jr. Calcium Regulating Hormones and Bone Metabolism. 1992;275-280 Elsevier Science Inc, New York.
20. Jilka R.L., Hangoc G., Girasole G., Passeri G., Williams D.C., Abrams J.S., Boyce B., Broxmeyer H., Manolagas S.C. Increased osteoclast development after estrogen loss mediation by interleukin-6 . Science. 257:1992;88-91.
21. Klein B., Zhang Z.Y., Bataille R. Interleukin-6 in human multiple myeloma. Blood. 85:1995;863-872.
22. Littlewood A.J., Russell J., Harvey G.R., Hughes D.E., Russell R.G.G., Gowen M. The modulation of the expression of IL-6 and its receptor in osteoblasts in vitro. Endocrinology. 129:1991;1513-1520.
23. Lorenzo J.A., Naprta A., Rao Y., Alander C., Glaccum M., Widmer M., Gronowicz G., Kalinowski J., Pilbeam C.C. Mice lacking the type I interleukin-1 receptor do not lose bone after ovariectomy. Endocrinology. 139:1998;3022-3025.
24. Lowik C.W.G.M. 1992. Differentiation inducing factors leukemia inhibitory factor and interleuikin-6 . Gowen M. Cytokines and Bone Metabolism. 1992;299-324 CRC, London.
25. McCarthy T.L., Centrella M., Canalis E. Further biochemical and molecular characterization of primary rat parietal bone cells. J Bone Miner Res. 3:1988;401-408.
26. Northemann W., Braciak T.A., Hattori M., Lee F., Fey G.H. Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells. J Biol Chem. 264:1989;16072-16082.
27. Pacifici R. Cytokines, estrogen, and postmenopausal osteoporosis the second decade . Endocrinology. 139:1998;2659-2660. [Editorial].
28. Pfeilschifter J., Seyedin S.M., Mundy G.R. Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures. J Clin Invest. 82:1988;680-685.
29. Robey P.G., Young M.F., Flanders K.C., Roche N.S., Kondaiah P., Reddi A.H., Termine J.D., Sporn M.B., Roberts A.B. Osteoblasts synthesize and respond to transforming growth factor factor type beta (TGFβ) in vitro. J Cell Biol. 105:1987;457-463.
30. Roodman G.D. Interleukin-6 an osteotropic factor? J Bone Miner Res. 7:1992;475-478.
31. Sano Y., Harada J., Tashiro S., Gotoh-Mandeville R., Maekawa T., Ishii S. ATF-2 is a common nuclear target of Smad and TAK-1 pathways in transforming growth factor-β signaling. J Biol Chem. 274:1999;8949-8957.
32. Seghal P.B. Regulation of IL-6 gene expression. Res Immunol. 143:1992;724-734.
33. Tamura, T. N., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., and Taga, T. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci USA 90:11924-1128; 1993.
34. Urashima M., Ogata A., Chauhan D., Hatziyanni M., Vidriales M.B., Dedera D.A., Sclossman R.L., Anderson K.C. Transforming growth factor-β 1 differential effects on multiple myeloma versus normal B cells . Blood. 5:1996;1928-1938.